Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
50.2% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
3.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
7 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
1.4% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
1
users have commented on this narrative
8
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Seplat Energy
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Increasing Nigerian Gas Production Will Spur Demand Amid Challenges
Key Takeaways Expansion in gas production and integration of new assets positions Seplat to capture growing demand and increase market share in Nigeria's cleaner energy sector. Operational efficiencies, low leverage, and strong liquidity enable Seplat to pursue acquisitions and maintain sustainable earnings growth.
View narrative
UK£3.28
FV
23.9% undervalued
intrinsic discount
11.37%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
5 days ago
author updated this narrative
Lincoln Electric Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Automation And Advanced Welding Will Stimulate Future Demand
Key Takeaways Rising automation, reshoring trends, and infrastructure spending are set to boost demand for advanced welding solutions and drive sustained revenue and margin growth. Focus on premium products, operational efficiency, and digital solutions supports long-term earnings expansion and strengthens stable, recurring revenue streams.
View narrative
US$250.50
FV
5.0% undervalued
intrinsic discount
5.41%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
6 days ago
author updated this narrative
Krishna Institute of Medical Sciences
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts
New Facilities In India Will Unlock Rising Healthcare Demand
Key Takeaways Expansion into emerging cities and investment in specialized care strengthen market position, supporting sustained revenue and margin growth as new facilities mature. Temporary challenges from insurance delays are expected to reverse, unlocking greater patient volumes and accelerating profitability with improved payer diversity and operational leverage.
View narrative
₹773.62
FV
0.6% undervalued
intrinsic discount
25.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
5 days ago
author updated this narrative
Innolux
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Embracing eLEAP And Fan-Out PLP Technologies Will Provide Future Advantages Amid Industry Cycles
Key Takeaways Investing in premium, advanced panels and strategic technology collaborations could boost revenue growth and enhance net margins in high-value sectors. Diversifying into high-margin non-commodity markets aims to stabilize earnings and increase profitability by reducing volatility exposure.
View narrative
NT$13.79
FV
7.2% undervalued
intrinsic discount
2.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
GMRA
GMR Airports
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Airport Expansions At Hyderabad And Mopa Will Increase Future Passenger Traffic
Key Takeaways Expansion projects and improved tariffs at key airports likely enhance revenue and earnings growth for GMR Airports. Non-aero revenue and reduced debt costs position the company for stronger profitability.
View narrative
₹94.75
FV
4.5% undervalued
intrinsic discount
24.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
5 days ago
author updated this narrative
Cardlytics
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Bank Partnerships And Data-Driven Marketing Will Shape Future Markets
Key Takeaways Expansion into diverse partnerships and innovative platforms increases user engagement and positions the company for sustainable revenue growth and operational scale. Enhanced data privacy compliance and advanced analytics strengthen advertiser loyalty, create pricing power, and boost recurring, high-margin revenue streams.
View narrative
US$1.63
FV
30.8% undervalued
intrinsic discount
-10.26%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
5 days ago
author updated this narrative
CureVac
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
GSK Milestones And Tech Focus Will Shape Oncology Amid Risks
Key Takeaways Strategic focus on innovation and R&D in oncology and infectious diseases positions CureVac for potential high-growth opportunities and revenue enhancement. Strong intellectual property, promising GSK licensing agreements, and a solid cash position bolster competitive edge and future revenue prospects.
View narrative
US$5.35
FV
1.9% overvalued
intrinsic discount
-33.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
21 days ago
author updated this narrative
CytomX Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Late-Stage Trials And Partnerships Will Advance Precision Medicine Despite Setbacks
Key Takeaways Success of clinical candidates and unique tumor-targeting technology could enable regulatory progress, commercial expansion, and attract additional partnerships and licensing agreements. Increasing global cancer rates and strategic industry collaborations support diversified revenue streams, improved cash flow, and long-term growth opportunities.
View narrative
US$5.75
FV
63.1% undervalued
intrinsic discount
-31.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
5 days ago
author updated this narrative
Bankwell Financial Group
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Technology Investments And SBA Expansion Will Advance Community Banking
Key Takeaways Expansion of deposit teams and digital efficiencies are strengthening growth, reducing funding costs, and improving profitability while broadening market reach. Enhanced SBA lending, better asset quality, and favorable market dynamics are diversifying income streams and supporting sustainable long-term revenue growth.
View narrative
US$45.00
FV
10.4% undervalued
intrinsic discount
28.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
Value any company in seconds
Popular companies